FDA approves two minimally invasive heartburn treatments
This article was originally published in Clinica
Executive Summary
The US FDA has approved Curon Medical's radiofrequency-based (RF) Stretta system for use in chronic heartburn, making it the second minimally invasive treatment for the condition to be cleared for marketing in a month. Earlier in April, CR Bard's endoscopic suturing system was approved for use in patients with chronic heartburn, or gastroesophageal reflux disease (GERD) (see Clinica No 904, p 18).